Oncology Reports

Papers
(The TQCC of Oncology Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Protein components of maple syrup as a potential resource for the development of novel anti‑colorectal cancer drugs140
Loss of CD24 promotes radiation‑ and chemo‑resistance by inducing stemness properties associated with a hybrid E/M state in breast cancer cells94
Tinzaparin inhibits VL30 retrotransposition induced by oxidative stress and/or VEGF in HC11 mouse progenitor mammary cells: Association between inhibition of cancer stem cell proliferation and mammosp66
[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma61
Impact of miRNAs involved in the STAT3 signaling pathway on esophageal cancer (Review)55
[Corrigendum] TOOLBOX: Strep‑Tagged nano‑assemblies of antibody‑drug‑conjugates (ADC) for modular and conditional cancer drugging52
Transitioning from molecular methods to therapeutic methods: An in‑depth analysis of glioblastoma (Review)43
[Corrigendum] MicroRNA‑379‑5p plays a tumor‑suppressive role in human bladder cancer growth and metastasis by directly targeting MDM240
Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis35
Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma33
New insights from Whole Genome Sequencing: BCLAF1 deletion as a structural variant that predisposes cells towards cellular transformation33
5‑Aza‑dC suppresses melanoma progression by inhibiting GAS5 hypermethylation31
[Corrigendum] HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma28
Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells27
[Retracted] Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK26
[Retracted] MicroRNA‑454 inhibits the malignant biological behaviours of gastric cancer cells by directly targeting mitogen‑activated protein kinase 124
[Retracted] microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a24
[Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR24
[Retracted] miR‑124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT324
[Retracted] MicroRNA‑663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF‑β123
[Retracted] Hypoxia‑induced mitochondrial translocation of DNM1L increases mitochondrial fission and triggers mPTP opening in HCC cells via activation of HK223
[Retracted] MicroRNA‑22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma22
[Retracted] MicroRNA‑874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X‑linked inhibitor of apoptosis protein22
[Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R21
[Retracted] miR‑363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F321
[Retracted] MicroRNA‑153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma21
[Retraction] MicroRNA‑491‑5p suppresses cervical cancer cell growth by targeting hTERT21
[Retracted] Synergistic effects of co‑expression plasmid‑based ADAM10‑specific siRNA and GRIM‑19 on hepatocellular carcinoma in vitro and in vivo21
[Retracted] miR‑489 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways20
[Retracted] microRNA‑196b promotes cell migration and invasion by targeting FOXP2 in hepatocellular carcinoma20
[Retracted] Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer19
[Retracted] MicroRNA‑326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 119
[Retracted] LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑HSPA919
[Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells19
[Retracted] Overexpression of miR‑203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf‑119
[Corrigendum] Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis18
lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis18
LASS2 overexpression enhances early apoptosis of lung cancer cells through the caspase‑dependent pathway18
Progression of melanoma is suppressed by targeting all transforming growth factor‑β isoforms with an Fc chimeric receptor18
DANCR promotes glioma cell autophagy and proliferation via the miR‑33b/DLX6/ATG7 axis18
Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF118
Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer18
Inhibitor of Wnt receptor 1 suppresses the effects of Wnt1, Wnt3a and β‑catenin on the proliferation and migration of C6 GSCs induced by low‑dose radiation17
β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells17
Metabolism‑related pharmacokinetic drug‑drug interactions with poly (ADP‑ribose) polymerase inhibitors (Review)17
CD14, a novel surface marker of esophageal cancer stem cells17
Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells17
Effect of shRNA‑mediated knockdown EBF1 gene expression on the proliferation of lung cancer cell line A549 in vitro and in vivo17
ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment17
RHBDD2‑WWOX protein interaction during proliferative and differentiated stages in normal and breast cancer cells16
Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro16
RB1‑promoter methylation in glioblastoma: A rare event in glioblastoma16
[Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity16
MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression16
m6A methyltransferase METTL14‑mediated RP1‑228H13.5 promotes the occurrence of liver cancer by targeting hsa‑miR‑205/ZIK116
Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) b16
The role of lncRNA binding to RNA‑binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review)15
The molecular mechanisms of chemotherapeutic resistance in tumors (Review)15
Progress in antitumor mechanisms and applications of phenformin (Review)15
Routes and molecular mechanisms of central nervous system involvement in acute myeloid leukemia (Review)15
Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer14
CUDC‑907 suppresses epithelial‑mesenchymal transition, migration and invasion in a 3D spheroid model of bladder cancer14
PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer14
Chronic stress promotes glioma cell proliferation via the PI3K/Akt signaling pathway14
Xiaotan Sanjie decoction normalizes tumor permissive microenvironment in gastric cancer (Review)14
EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells14
Epithelial‑derived head and neck squamous tumourigenesis (Review)14
Cep63 knockout inhibits the malignant phenotypes of papillary thyroid cancer cell line TPC‑114
Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway13
[Rectacted] miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN13
Exploring stage‑specific embryonic antigen 3 involvement in oral cancer progression and as a potential target for taxane‑based chemotherapy13
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance13
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance13
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway13
Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines13
Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors13
Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)13
Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma13
Noncoding RNAs as key modulators of autophagy in pancreatic cancer (Review)13
Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma13
Genome‑wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor‑resistant CML cells13
Cysteine‑ and glycine‑rich protein 2: A vital regulator that inhibits necroptosis glioma cell by activating the JAK‑STAT1 pathways13
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)13
[Corrigendum] lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway12
HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer12
Downregulation of matriptase suppresses the PAR‑2/PLCγ2/PKC‑mediated invasion and migration abilities of MCF‑7 breast cancer cells12
Long non‑coding RNA H19 regulates LASP1 expression in osteosarcoma by competitively binding to miR‑29a‑3p12
Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review)12
[Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT‑related genes Snail and E‑cadherin12
Overview of serpin B9 and its roles in cancer (Review)12
Protein phosphatase 2A regulated by USP7 is polyubiquitinated and polyneddylated12
Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis12
Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt12
MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review)12
Wnt signaling promotes tumor development in part through phosphofructokinase 1 platelet isoform upregulation11
p‑STAT3 influences doxorubicin and etoposide resistance of A549 cells grown in an in vitro 3D culture model11
Role of SIK1 in tumors: Emerging players and therapeutic potentials (Review)11
Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming11
Antitumor effect of curcumin analog on osteosarcoma through the inhibition of p300‑mediated histone acetylation11
miR‑491‑3p functions as a tumor suppressor in non‑small cell lung cancer by targeting fibroblast growth factor 511
Biomarkers for evaluating the clinical response to immune checkpoint inhibitors in renal cell carcinoma (Review)11
Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia11
Long non‑coding RNAs interact with RNA‑binding proteins to regulate genomic instability in cancer cells (Review)11
RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA11
Repurposing the antipsychotic drug penfluridol for cancer treatment (Review)11
Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma10
The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review)10
Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer10
Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review)10
Hypoxia induces radioresistance, epithelial‑mesenchymal transition, cancer stem cell‑like phenotype and changes in genes possessing multiple biological functions in head and neck squamous cell carcino10
IFNγ enhances ferroptosis by increasing JAK‑STAT pathway activation to suppress SLCA711 expression in adrenocortical carcinoma10
FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization10
GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via fatty acid oxidation metabolic reprogramming mediated by the miR‑5572/6855‑5p/CPT1A axis10
Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin10
Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway10
Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions10
EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system10
Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)10
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells10
BCG immunotherapy inhibits cancer progression by promoting the M1 macrophage differentiation of THP‑1 cells via the Rb/E2F1 pathway in cervical carcinoma10
miR‑367‑3p downregulates Rab23 expression and inhibits Hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells10
Pseudolaric acid B induces apoptosis associated with the mitochondrial and PI3K/AKT/mTOR pathways in triple‑negative breast cancer10
Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review)10
ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells10
Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI210
Starvation insult induces the translocation of high mobility group box 1 to cytosolic compartments in glioma10
[Corrigendum] Nucleosome‑binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2‑OS osteosarcoma cell lines10
Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP29
Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review)9
Thermal cycling‑hyperthermia sensitizes non‑small cell lung cancer A549 cells to EGFR tyrosine kinase inhibitor erlotinib9
Cepharanthine hydrochloride inhibits the Wnt/β‑catenin/Hedgehog signaling axis in liver cancer9
Aggressive local therapy for de novo metastatic breast cancer: Challenges and updates (Review)9
Regulators of epigenetic change in ferroptosis‑associated cancer (Review)9
Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline9
Apigenin inhibits renal cell carcinoma cell proliferation through G2/M phase cell cycle arrest9
Effect of quercetin on inhibiting gefitinib‑activated non‑small cell lung cancer‑induced cell pyroptosis in cardiomyocytes via modulating mitochondrial autophagy mediated by the SHP2/ROS/AMPK/XBP‑1/DJ9
[Retracted] Ruscogenin induces ferroptosis in pancreatic cancer cells9
[Retracted] MicroRNA‑616 promotes the growth and metastasis of non‑small cell lung cancer by targeting SOX79
Repurposing propofol for breast cancer therapy through promoting apoptosis and arresting cell cycle9
Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression9
SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression9
Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro9
[Retracted] Dual inhibition of COX‑2/5‑LOX blocks colon cancer proliferation, migration and invasion in vitro9
Establishment and characterization of novel autologous pair cell lines from two Indian non‑habitual tongue carcinoma patients9
SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen‑receptor‑positive breast cancer9
Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment8
Histological tumor necrosis in pancreatic cancer after neoadjuvant therapy8
Characterization of morphological alterations in micropapillary adenocarcinoma of the lung using an established cell line8
High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer8
[Corrigendum] Altered expression of miR‑152 and miR‑148a in ovarian cancer is related to cell proliferation8
Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review)8
Engineered extracellular vesicles with polypeptide for targeted delivery of doxorubicin against EGFR‑positive tumors8
Lung cancer and obesity: A contentious relationship (Review)8
Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)8
α‑Phellandrene enhances the apoptosis of HT‑29 cells induced by 5‑fluorouracil by modulating the mitochondria‑dependent pathway8
Characterization of the nucleotide excision repair pathway and evaluation of compounds for overcoming the cisplatin resistance of non‑small cell lung cancer cell lines8
Important role and underlying mechanism of non‑SMC condensin I complex subunit G in tumours (Review)8
[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M18
Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review)8
miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis8
[Retracted] MicroRNA‑9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC18
Macrophage renewal modes affect acquired resistance to gefitinib in EGFR‑mutant lung cancer PC‑9 cells8
[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway8
Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)8
RORβ suppresses the stemness of gastric cancer cells by downregulating the activity of the Wnt signaling pathway8
Binding between ROCK1 and DCTN2 triggers diabetes‑associated centrosome amplification in colon cancer cells8
Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis8
[Corrigendum] 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR58
Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review)8
[Corrigendum] Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro8
[Retracted] Tissue‑specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA‑125a‑5p in lung cancer8
[Corrigendum] Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway8
[Corrigendum] TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma8
miR‑375/Yes‑associated protein axis regulates IL‑6 and TGF‑β expression, which is involved in the cisplatin‑induced resistance of liver cancer cells8
β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy8
[Corrigendum] RON and c‑Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells8
Androgen deprivation‑induced OPHN1 amplification promotes castration‑resistant prostate cancer8
5‑Aminolevurinic acid inhibits the proliferation of bladder cancer cells by activating heme synthesis8
Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer8
The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review)7
Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review)7
[Corrigendum] PRIMA‑1met induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‑ULK1‑Vps34 signaling cascade7
Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation7
Role of reactive oxygen species in tumors based on the ‘seed and soil’ theory: A complex interaction (Review)7
SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO17
[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression7
CircRPPH1 accelerates the proliferation and migration of bladder cancer via enhancing the STAT3 signaling pathway7
The human microbiome links to prostate cancer risk and treatment (Review)7
[Corrigendum] BCL‑3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D17
Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair7
NCoA3 upregulation in breast cancer‑associated adipocytes elicits an inflammatory profile7
Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)7
Dehydrocrenatidine extracted from Picrasma quassioides induces the apoptosis of nasopharyngeal carcinoma cells through the JNK and ERK signaling pathways7
Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway7
[Corrigendum] Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level7
Extracellular vesicle‑mediated RNA editing may underlie the heterogeneity and spread of hepatocellular carcinoma in human tissue and in vitro7
[Corrigendum] Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway7
KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells7
Inhibition of protein arginine deiminase II suppresses retinoblastoma in orthotopic transplantation in mice7
AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells7
Unveiling the best predictive models for early‑onset metastatic cancer: Insights and innovations (Review)7
Tetraspanin CD9: A friend or foe of head and neck cancer (Review)7
Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma7
In vitro induction of mitotic catastrophe as a therapeutic approach for oral cancer using the ethanolic extract of Juniperus squamata7
[Retracted] miRNA‑490‑3p promotes the metastatic progression of invasive ductal carcinoma7
Comparison of the multigene panel test and OncoScan™ for the determination of HER2 amplification in breast cancer7
RASSF10 exhibits tumor‑suppressing potential involving tumor proliferation, metastasis and epithelial‑mesenchymal transition in esophageal squamous cell carcinoma7
Inhibitory effects of terrein on lung cancer cell metastasis and angiogenesis7
Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer7
HELQ as a DNA helicase: Its novel role in normal cell function and tumorigenesis (Review)7
Intra‑tumor heterogeneity of cancer stem cell‑related genes and their potential regulatory microRNAs in metastasizing colorectal carcinoma6
DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma6
Role of MRI‑based radiomics in locally advanced rectal cancer (Review)6
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR6
METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression6
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)6
Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the MET pathway in glioblastoma cells6
Mitochondrial‑associated endoplasmic reticulum membrane interference in ovarian cancer (Review)6
Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway6
Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin6
Anti‑tumor effects of an aqueous extract ofEcklonia cavain BALB/cKorl syngeneic mice using colon carcinoma CT26 cells6
A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review)6
In vitro characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line6
Administration of 4‑hexylresorcinol increases p53‑mediated transcriptional activity in oral cancer cells with the p53 mutation6
[Corrigendum] FNDC3B promotes epithelial‑mesenchymal transition in tongue squamous cell carcinoma cells in a hypoxic microenvironment6
Establishment of a three‑dimensional triculture model on the novel AXTEX‑4D™ platform6
AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization6
LMP1 mediates tumorigenesis through persistent epigenetic modifications and PGC1β upregulation6
[Retracted] MicroRNA‑329‑3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer6
Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review)6
Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer6
Levels of circulating mast cell progenitors and tumour‑infiltrating mast cells in patients with colorectal cancer6
Culture of circulating tumor cells using a microfilter device6
Nuclear IGF1R interacts with NuMA and regulates 53BP1‑dependent DNA double‑strand break repair in colorectal cancer6
Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities6
Forkhead box F1 functions as a novel prognostic biomarker and induces caspase‑dependent apoptosis in bladder cancer6
Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)6
SNAI2 enhances HPV‑negative cervical cancer cell dormancy by modulating u‑PAR expression and the activity of the ERK/p38 signaling pathway in vitro6
Anterior gradient 2 regulates cancer progression in TP53‑wild‑type esophageal squamous cell carcinoma6
0.12949013710022